2024 Q2 Form 10-K Financial Statement

#000149315224014860 Filed on April 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $13.00K $14.00K $12.00K
YoY Change 180.0% -91.11%
Cost Of Revenue $0.00
YoY Change -100.0%
Gross Profit $12.00K
YoY Change -88.89%
Gross Profit Margin 100.0%
Selling, General & Admin $2.882M $4.910M
YoY Change -53.85% -16.82%
% of Gross Profit 40916.67%
Research & Development $342.0K $200.0K $1.176M
YoY Change -79.88% -81.82% 5.0%
% of Gross Profit 9800.0%
Depreciation & Amortization $49.00K $78.00K $91.00K
YoY Change -46.74% -7.14% 9.64%
% of Gross Profit 758.33%
Operating Expenses $5.305M $3.451M $6.179M
YoY Change -51.37% -53.31% -13.05%
Operating Profit -$5.292M -$3.437M -$6.167M
YoY Change -51.49% -53.47% -11.87%
Interest Expense -$3.000K $1.000K
YoY Change -175.0% -50.0%
% of Operating Profit
Other Income/Expense, Net -$2.000K $25.00K $38.00K
YoY Change -99.11%
Pretax Income -$3.911M -$3.415M -$6.128M
YoY Change -64.86% -53.74% -12.41%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$3.915M -$3.402M -$6.051M
YoY Change -64.71% -53.6% -14.11%
Net Earnings / Revenue -30115.38% -24300.0% -50425.0%
Basic Earnings Per Share -$0.30 -$0.36
Diluted Earnings Per Share -$0.30 -$0.36 -$0.70
COMMON SHARES
Basic Shares Outstanding 11.20M shares 9.856M shares 88.11M shares
Diluted Shares Outstanding 12.92M shares 9.856M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $506.0K $293.0K
YoY Change -66.56% -36.03%
Cash & Equivalents $2.104M $416.0K $200.0K
Short-Term Investments $90.00K $103.0K
Other Short-Term Assets $211.0K
YoY Change -35.08%
Inventory $0.00
Prepaid Expenses $163.0K $220.0K $206.0K
Receivables $54.00K $14.00K $24.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.386M $740.0K $528.0K
YoY Change 20.08% -65.58% -53.19%
LONG-TERM ASSETS
Property, Plant & Equipment $137.0K $182.0K $921.0K
YoY Change -77.94% -71.11% 38.5%
Goodwill
YoY Change
Intangibles $1.000K $1.000K
YoY Change 0.0% 0.0%
Long-Term Investments $4.000K $17.00K
YoY Change -95.74% -85.83%
Other Assets $43.00K $43.00K
YoY Change -82.38% -2.27%
Total Long-Term Assets $721.0K $849.0K $1.270M
YoY Change -65.05% -72.14% -57.41%
TOTAL ASSETS
Total Short-Term Assets $2.386M $740.0K $528.0K
Total Long-Term Assets $721.0K $849.0K $1.270M
Total Assets $3.107M $1.589M $1.798M
YoY Change -23.28% -69.42% -56.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $5.129M $4.465M
YoY Change 89.05% 41.07%
Deferred Revenue $16.00K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.976M $5.232M $4.582M
YoY Change -10.68% 85.93% 40.51%
LONG-TERM LIABILITIES
Long-Term Debt $500.0K $0.00
YoY Change
Other Long-Term Liabilities $60.00K $103.0K
YoY Change -83.7% -77.21%
Total Long-Term Liabilities $15.00K $560.0K $103.0K
YoY Change -94.68% 52.17% -77.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.976M $5.232M $4.582M
Total Long-Term Liabilities $15.00K $560.0K $103.0K
Total Liabilities $2.991M $5.792M $4.711M
YoY Change -17.24% 82.02% 26.88%
SHAREHOLDERS EQUITY
Retained Earnings -$252.3M -$248.4M -$245.0M
YoY Change 7.65% 11.25% 13.45%
Common Stock $15.00K $11.00K $9.000K
YoY Change -79.45% -83.58% -83.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.000K -$4.321M -$2.913M
YoY Change
Total Liabilities & Shareholders Equity $3.107M $1.589M $1.798M
YoY Change -23.28% -69.42% -56.25%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$3.915M -$3.402M -$6.051M
YoY Change -64.71% -53.6% -14.11%
Depreciation, Depletion And Amortization $49.00K $78.00K $91.00K
YoY Change -46.74% -7.14% 9.64%
Cash From Operating Activities -$1.300M -$2.943M
YoY Change -76.79% -28.46%
INVESTING ACTIVITIES
Capital Expenditures $6.000K
YoY Change -89.66%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$6.000K
YoY Change -89.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $5.000M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.540M 2.742M
YoY Change -77.18% -24.71%
NET CHANGE
Cash From Operating Activities -$1.300M -2.943M
Cash From Investing Activities -6.000K
Cash From Financing Activities $1.540M 2.742M
Net Change In Cash $240.0K -207.0K
YoY Change -78.24% -60.94%
FREE CASH FLOW
Cash From Operating Activities -$1.300M -$2.943M
Capital Expenditures $6.000K
Free Cash Flow -$1.300M -$2.949M
YoY Change -76.97% -29.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001530766
CY2022Q4 BSGM Employee Advance
EmployeeAdvance
usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
usd
CY2023Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
usd
CY2022 BSGM Adjustments To Additional Paid In Capital Issuance Of Subsidiary Stock In Settlement Of Debt To Parent
AdjustmentsToAdditionalPaidInCapitalIssuanceOfSubsidiaryStockInSettlementOfDebtToParent
usd
CY2023 BSGM Stock Issued During Period Value Common Stock Issued For Exercise Of Warrants Cashlessly
StockIssuedDuringPeriodValueCommonStockIssuedForExerciseOfWarrantsCashlessly
usd
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
usd
CY2023 us-gaap Equity Fair Value Adjustment
EquityFairValueAdjustment
usd
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
CY2022 BSGM Increase Decrease Customer Deposits
IncreaseDecreaseCustomerDeposits
usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
usd
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
usd
CY2023Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
usd
CY2023Q4 us-gaap Inventory Adjustments
InventoryAdjustments
usd
CY2023Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
usd
CY2023 us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
usd
CY2021Q4 us-gaap Sales Type Lease Net Investment In Lease
SalesTypeLeaseNetInvestmentInLease
usd
CY2023Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2022 BSGM Share Based Compensation Arrangement By Share Based Payment Award Options Grants Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsIntrinsicValue
usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2023 BSGM Share Based Compensation Arrangement By Share Based Payment Award Options Grants Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsIntrinsicValue
usd
CY2023 BSGM Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Expired Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedExpiredIntrinsicValue
usd
CY2022Q1 BSGM Class Of Warrant Or Rights Outstanding Intrinsic Value
ClassOfWarrantOrRightsOutstandingIntrinsicValue
usd
CY2023Q4 BSGM Class Of Warrant Or Rights Outstanding Intrinsic Value
ClassOfWarrantOrRightsOutstandingIntrinsicValue
usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-38659
CY2023 dei Entity Registrant Name
EntityRegistrantName
BIOSIG TECHNOLOGIES, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-4333375
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
55 Greens Farms Road 1st Floor
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
76956461 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11198174 shares
CY2023 dei Auditor Firm
AuditorFirmId
688
CY2023 dei Auditor Name
AuditorName
Marcum LLP
CY2023 dei Auditor Location
AuditorLocation
Marlton, New Jersey
CY2023Q4 us-gaap Cash
Cash
190000 usd
CY2022Q4 us-gaap Cash
Cash
357000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
24000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9000 usd
CY2023Q4 BSGM Employee Advance
EmployeeAdvance
5000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
336000 usd
CY2023Q4 us-gaap Sales Type Lease Lease Receivable
SalesTypeLeaseLeaseReceivable
103000 usd
CY2022Q4 us-gaap Sales Type Lease Lease Receivable
SalesTypeLeaseLeaseReceivable
101000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
206000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
325000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
528000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1128000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
509000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
665000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
412000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
705000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
1141000 usd
CY2023Q4 us-gaap Sales Type And Direct Financing Leases Lease Receivable
SalesTypeAndDirectFinancingLeasesLeaseReceivable
17000 usd
CY2022Q4 us-gaap Sales Type And Direct Financing Leases Lease Receivable
SalesTypeAndDirectFinancingLeasesLeaseReceivable
120000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
288000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
307000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
44000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
44000 usd
CY2023Q4 us-gaap Assets
Assets
1798000 usd
CY2022Q4 us-gaap Assets
Assets
4110000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4116000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2852000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
16000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5000 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
101000 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
91000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
349000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
313000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4582000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3261000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
103000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
452000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
103000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
452000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
4685000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
3713000 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
105000 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
105000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9040043 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9040043 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5505068 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5505068 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
9000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
241988000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
216282000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-245015000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-215974000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3018000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
313000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
26000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-21000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2992000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
292000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1798000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4110000 usd
CY2023 us-gaap Revenues
Revenues
18000 usd
CY2022 us-gaap Revenues
Revenues
286000 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
57000 usd
CY2023 us-gaap Gross Profit
GrossProfit
18000 usd
CY2022 us-gaap Gross Profit
GrossProfit
229000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5092000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5821000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23077000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21380000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
361000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
293000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
28530000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
27494000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-28512000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-27265000 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-187000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-28690000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27262000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-28690000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-27262000 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
351000 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-210000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-29041000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-27052000 usd
CY2023 us-gaap Dividends Preferred Stock
DividendsPreferredStock
9000 usd
CY2022 us-gaap Dividends Preferred Stock
DividendsPreferredStock
9000 usd
CY2022 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
210000 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-29050000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-27271000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.95
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.95
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.33
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.33
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7351794 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7351794 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4307244 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4307244 shares
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12460000 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2109000 usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
528000 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
8283000 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2070000 usd
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.50
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
218000 usd
CY2022 BSGM Stock Issued During Period Value Issued In Settlement Of Debt
StockIssuedDuringPeriodValueIssuedInSettlementOfDebt
105000 usd
CY2022 BSGM Adjustments To Additional Paid In Capital Change In Fair Value Of Modified Options
AdjustmentsToAdditionalPaidInCapitalChangeInFairValueOfModifiedOptions
15000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2303000 usd
CY2022 us-gaap Dividends Preferred Stock Paidinkind
DividendsPreferredStockPaidinkind
210000 usd
CY2022 BSGM Deemed Preferred Stock Dividend
DeemedPreferredStockDividend
210000 usd
CY2022 us-gaap Dividends Preferred Stock
DividendsPreferredStock
9000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-27262000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
292000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
292000 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
7617000 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
7617000 usd
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1067000 usd
CY2023 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
15301000 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
60000 usd
CY2023 BSGM Stock Issued During Period Value Issued In Settlement Of Debt
StockIssuedDuringPeriodValueIssuedInSettlementOfDebt
105000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
1971000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
361000 usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
218000 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
60000 usd
CY2023 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
15301000 usd
CY2023 us-gaap Dividends Preferred Stock
DividendsPreferredStock
9000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-28690000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2992000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2992000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-28690000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-27262000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
361000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
293000 usd
CY2023 BSGM Non Cash Lease Expense
NonCashLeaseExpense
293000 usd
CY2022 BSGM Non Cash Lease Expense
NonCashLeaseExpense
373000 usd
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
1976000 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7978000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4412000 usd
CY2022 us-gaap Equity Fair Value Adjustment
EquityFairValueAdjustment
-15000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9000 usd
CY2023 us-gaap Increase Decrease In Leasing Receivables
IncreaseDecreaseInLeasingReceivables
-101000 usd
CY2022 us-gaap Increase Decrease In Leasing Receivables
IncreaseDecreaseInLeasingReceivables
220000 usd
CY2023 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
5000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
498000 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-284000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-118000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-30000 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-5000 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-32000 usd
CY2023 BSGM Increase Decrease Customer Deposits
IncreaseDecreaseCustomerDeposits
16000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1370000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
776000 usd
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-313000 usd
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-365000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17313000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21705000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
186000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
168000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-186000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-168000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15301000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8283000 usd
CY2023 BSGM Proceeds From Proceeds From Sale Of Common Stock Under A At The Market Offerings Net Of Issuance Costs
ProceedsFromProceedsFromSaleOfCommonStockUnderAAtTheMarketOfferingsNetOfIssuanceCosts
60000 usd
CY2022 BSGM Proceeds From Proceeds From Sale Of Common Stock Under A At The Market Offerings Net Of Issuance Costs
ProceedsFromProceedsFromSaleOfCommonStockUnderAAtTheMarketOfferingsNetOfIssuanceCosts
2070000 usd
CY2023 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
1971000 usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
218000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17332000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10571000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-167000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-11302000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
357000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11659000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
190000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
357000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
1000 usd
CY2023 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
105000 usd
CY2022 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
105000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
9000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
9000 usd
CY2022 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
210000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
502000 usd
CY2019 us-gaap Stockholders Equity Other Shares
StockholdersEquityOtherShares
894869 shares
CY2020 us-gaap Stockholders Equity Other Shares
StockholdersEquityOtherShares
894869 shares
CY2024Q1 BSGM Priceper Share
PriceperShare
1.00
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5000000 usd
CY2024Q2 us-gaap Auction Market Preferred Securities Stock Series Liquidation Value
AuctionMarketPreferredSecuritiesStockSeriesLiquidationValue
35000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
200000 usd
CY2023Q4 BSGM Working Capital Deficit
WorkingCapitalDeficit
4100000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17300000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
5000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_zhZcptOovJR9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of these consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the recoverability and useful lives of long-lived assets, stock-based compensation and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
4333 usd
CY2022Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P30M
CY2022Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P1Y
CY2022 BSGM Lessor Sales Type Lease Discount Rate
LessorSalesTypeLeaseDiscountRate
0.02 pure
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
37000 usd
CY2022 us-gaap Contract With Customer Asset Purchase
ContractWithCustomerAssetPurchase
254000 usd
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-286000 usd
CY2022Q4 us-gaap Policyholder Funds
PolicyholderFunds
5000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zOeBfdZocI3g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zaPlZKz2IHLl">Concentrations of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents. The Company places its cash and temporary cash investments with credit quality institutions. At times, such amounts may be in excess of the FDIC insurance limit. At December 31, 2023 and 2022, deposits in excess of FDIC limits were <span id="xdx_90F_eus-gaap--CashUninsuredAmount_iI_dxL_c20231231_znZF30mMIRul" title="Cash, uninsured amount::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0817">nil</span></span> and $<span id="xdx_903_eus-gaap--CashUninsuredAmount_iI_pn4n6_c20221231_zYDmVZUeNi29" title="Cash, uninsured amount">0.05</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
50000.00 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1976000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1477000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1976000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1477000 usd
CY2022Q4 us-gaap Inventory Adjustments
InventoryAdjustments
336000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
1141000 usd
CY2023Q4 BSGM Allowance For Inventory
AllowanceForInventory
1976 usd
CY2023Q4 us-gaap Security Deposit
SecurityDeposit
43000 usd
CY2022Q4 us-gaap Security Deposit
SecurityDeposit
43000 usd
CY2023Q4 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
1000 usd
CY2022Q4 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
1000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
44000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
44000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5100000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5800000 usd
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3580561 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
966779 shares
CY2023 us-gaap Adjustment For Amortization
AdjustmentForAmortization
19106 usd
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
19006 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1452000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1266000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
943000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
601000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
509000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
665000 usd
CY2023 us-gaap Depreciation
Depreciation
342028 usd
CY2022 us-gaap Depreciation
Depreciation
273915 usd
CY2023 BSGM Number Of Leases
NumberOfLeases
2 integer
CY2023Q4 BSGM Operating Lease Right To Use Assets Gross
OperatingLeaseRightToUseAssetsGross
995000 usd
CY2022Q4 BSGM Operating Lease Right To Use Assets Gross
OperatingLeaseRightToUseAssetsGross
995000 usd
CY2023Q4 BSGM Operating Lease Right To Use Asset Accumulated Depreciation
OperatingLeaseRightToUseAssetAccumulatedDepreciation
583000 usd
CY2022Q4 BSGM Operating Lease Right To Use Asset Accumulated Depreciation
OperatingLeaseRightToUseAssetAccumulatedDepreciation
290000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
412000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
705000 usd
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
378263 usd
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
438129 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
452000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
765000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
349000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
313000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
103000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
452000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
370000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
106000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
476000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
24000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
452000 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
337000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
373000 usd
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
33000 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
37000 usd
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
8000 usd
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
28000 usd
CY2023 us-gaap Lease Cost
LeaseCost
378000 usd
CY2022 us-gaap Lease Cost
LeaseCost
438000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
4333 usd
CY2022Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P30M
CY2022Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P1Y
CY2022 BSGM Lessor Sales Type Lease Discount Rate
LessorSalesTypeLeaseDiscountRate
0.02 pure
CY2022Q4 us-gaap Sales Type Lease Unguaranteed Residual Asset
SalesTypeLeaseUnguaranteedResidualAsset
4000 usd
CY2022Q4 us-gaap Sales Type Lease Net Investment In Lease
SalesTypeLeaseNetInvestmentInLease
221000 usd
CY2023 BSGM Sales Type Lease Invoiced To Customer
SalesTypeLeaseInvoicedToCustomer
-100000 usd
CY2023 us-gaap Sales Type Lease Interest Income Lease Receivable
SalesTypeLeaseInterestIncomeLeaseReceivable
3000 usd
CY2023Q4 us-gaap Sales Type Lease Unguaranteed Residual Asset
SalesTypeLeaseUnguaranteedResidualAsset
4000 usd
CY2023Q4 us-gaap Sales Type Lease Net Investment In Lease
SalesTypeLeaseNetInvestmentInLease
120000 usd
CY2022 us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
254000 usd
CY2022 BSGM Sales Type Lease Invoiced To Customer
SalesTypeLeaseInvoicedToCustomer
-39000 usd
CY2022 us-gaap Sales Type Lease Interest Income Lease Receivable
SalesTypeLeaseInterestIncomeLeaseReceivable
2000 usd
CY2022Q4 us-gaap Sales Type Lease Unguaranteed Residual Asset
SalesTypeLeaseUnguaranteedResidualAsset
4000 usd
CY2022Q4 us-gaap Sales Type Lease Net Investment In Lease
SalesTypeLeaseNetInvestmentInLease
221000 usd
CY2023Q4 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths
104000 usd
CY2023Q4 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
13000 usd
CY2023Q4 us-gaap Sales Type Lease Unguaranteed Residual Asset
SalesTypeLeaseUnguaranteedResidualAsset
4000 usd
CY2023Q4 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
121000 usd
CY2023Q4 us-gaap Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount
SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount
1000 usd
CY2023Q4 us-gaap Sales Type Lease Net Investment In Lease
SalesTypeLeaseNetInvestmentInLease
120000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1277000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
646000 usd
CY2023Q4 BSGM Accrued Reimbursements Current
AccruedReimbursementsCurrent
9000 usd
CY2022Q4 BSGM Accrued Reimbursements Current
AccruedReimbursementsCurrent
33000 usd
CY2023Q4 BSGM Accrued Consulting Current
AccruedConsultingCurrent
804000 usd
CY2022Q4 BSGM Accrued Consulting Current
AccruedConsultingCurrent
546000 usd
CY2023Q4 BSGM Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
802000 usd
CY2022Q4 BSGM Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
625000 usd
CY2023Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
333000 usd
CY2022Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
256000 usd
CY2023Q4 BSGM Accrued Office Expense And Other Expense
AccruedOfficeExpenseAndOtherExpense
290000 usd
CY2022Q4 BSGM Accrued Office Expense And Other Expense
AccruedOfficeExpenseAndOtherExpense
220000 usd
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
601000 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
513000 usd
CY2022Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
13000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4116000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2852000 usd
CY2022 BSGM Deemed Preferred Stock Dividend
DeemedPreferredStockDividend
209682 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9040043 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9040043 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5505068 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5505068 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
14.00
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.50
CY2022Q4 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
87300 shares
CY2022Q4 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
218250 usd
CY2022 BSGM Stock Issued During Period Value Issued For Services Fair Value
StockIssuedDuringPeriodValueIssuedForServicesFairValue
1060740 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
230000 usd
CY2023Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
77405 shares
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
7.85
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P6M
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
2200000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
the exercise price of an Incentive Stock Option should not be less than 110% of fair value of the common stock at the date of the grant for a 10% or more stockholder and 100% of fair value for a grantee who is not 10% stockholder
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P10Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
the exercise price of an Incentive Stock Option should not be less than 110% of fair value of the common stock at the date of the grant for a 10% or more stockholder and 100% of fair value for a grantee who is not 10% stockholder
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P10Y
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
603229 shares
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M12D
CY2023Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
386507 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
456852 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
45.70
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M24D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
142800 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.20
CY2022 BSGM Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1
P10Y
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
144100 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
455552 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
45.70
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M24D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
195710 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.00
CY2023 BSGM Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1
P10Y
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
48033 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
603229 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
25.67
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M12D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
37671000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
386507 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
33.53
CY2023 BSGM Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term3
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3
P5Y10M24D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
35425000 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice
4.75
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
142800 shares
CY2022 BSGM Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm
P10Y
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
195710 shares
CY2023 BSGM Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm
P10Y
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
7.72
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
8.00
CY2022Q1 BSGM Options Modified
OptionsModified
10000 shares
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
15181 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8386 pure
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1445915 usd
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1829233 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
997894 usd
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y6M7D
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2748371 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
32727 shares
CY2022Q4 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
90865 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9626 pure
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0382 pure
CY2023Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
126385 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
5.31
CY2022 BSGM Class Of Warrants Or Right Issued
ClassOfWarrantsOrRightIssued
427120 shares
CY2022 BSGM Warrants Weighted Average Remaining Contractual Term Issued
WarrantsWeightedAverageRemainingContractualTermIssued
P4Y
CY2022 BSGM Class Of Warrants Or Right Expried
ClassOfWarrantsOrRightExpried
-87300 shares
CY2022Q4 BSGM Class Of Warrant Or Rights Outstanding Intrinsic Value
ClassOfWarrantOrRightsOutstandingIntrinsicValue
3960 usd
CY2023 BSGM Class Of Warrants Or Right Issued
ClassOfWarrantsOrRightIssued
2332752 shares
CY2023 BSGM Warrants Weighted Average Remaining Contractual Term Issued
WarrantsWeightedAverageRemainingContractualTermIssued
P3Y9M18D
CY2023 BSGM Class Of Warrants Or Right Exercised
ClassOfWarrantsOrRightExercised
-6098 shares
CY2023Q4 BSGM Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Outstanding
ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding
7.40
CY2023 BSGM Warrants Outstanding Weighted Average Remaining Contractual Term
WarrantsOutstandingWeightedAverageRemainingContractualTerm
P3Y8M12D
CY2023 BSGM Warrants Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term
WarrantsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm
P3Y8M12D
CY2023Q4 BSGM Class Of Warrant Or Rights Vested And Expected To Vest Outstanding Intrinsic Value
ClassOfWarrantOrRightsVestedAndExpectedToVestOutstandingIntrinsicValue
1717104 usd
CY2023 BSGM Warrants Exercisable Weighted Average Remaining Contractual Term
WarrantsExercisableWeightedAverageRemainingContractualTerm
P3Y7M6D
CY2023Q4 BSGM Class Of Warrant Or Rights Exercisable Intrinsic Value
ClassOfWarrantOrRightsExercisableIntrinsicValue
1711424 usd
CY2023Q4 us-gaap Share Price
SharePrice
4.75
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
90865 usd
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
0 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
37750 shares
CY2023Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
26000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
vesting quarterly over one year
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
301600 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
vesting quarterly over one year, and 25,000 vesting on the one-year anniversary
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
190920 usd
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
the exercise price of an Incentive Stock Option should not be less than 110% of fair market value of the common stock at the date of the grant for a 10% or more stockholder and 100% of fair market value for a grantee who is not 10% stockholder
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2650071 shares
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y6M
CY2023 BSGM Warrants Granted Weighted Average Remaining Contractual Term
WarrantsGrantedWeightedAverageRemainingContractualTerm
P5Y
CY2023 BSGM Net Income Loss Of Non Controlling Interest
NetIncomeLossOfNonControllingInterest
753000 usd
CY2023 BSGM Average Noncontrolling Interest Percentage Of Profitlosses
AverageNoncontrollingInterestPercentageOfProfitlosses
0.47 pure
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
351000 usd
CY2022 BSGM Net Income Loss Of Non Controlling Interest
NetIncomeLossOfNonControllingInterest
-674000 usd
CY2022 BSGM Net Income Loss Of Non Controlling Interest
NetIncomeLossOfNonControllingInterest
-674000 usd
CY2022 BSGM Average Noncontrolling Interest Percentage Of Profitlosses
AverageNoncontrollingInterestPercentageOfProfitlosses
0.31 pure
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-210000 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
219000 usd
CY2022 BSGM Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Noncontrolling Interest For Settlement Of Shares Issued To Settle Debt To Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNoncontrollingInterestForSettlementOfSharesIssuedToSettleDebtToParent
292000 usd
CY2022 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Sale Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent
322000 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-210000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-21000 usd
CY2023 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Issuance Of Equity By Subsidiary To Noncontrolling Interests
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesIssuanceOfEquityBySubsidiaryToNoncontrollingInterests
296000 usd
CY2023 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Sale Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent
600000 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
351000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
26000 usd
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
229744 usd
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
247622 usd
CY2023 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
1563203 usd
CY2023Q4 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
775782 usd
CY2023 us-gaap Revenues
Revenues
18000 usd
CY2022 us-gaap Revenues
Revenues
286000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
28530000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
27494000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-28512000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-27265000 usd
CY2023Q4 us-gaap Assets
Assets
1798000 usd
CY2022Q4 us-gaap Assets
Assets
4110000 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
160926000 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
7739000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
47679000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
55418000 usd
CY2023 BSGM Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate1
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1
0.269 pure
CY2023 BSGM Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate1
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1
0.269 pure
CY2022 BSGM Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate1
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1
0.269 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.336 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.269 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.605 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.0000 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.0000 pure
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
43329000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
36977000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
9680000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
9291000 usd
CY2023Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
2409000 usd
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
1411000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
55418000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
47679000 usd

Files In Submission

Name View Source Status
0001493152-24-014860-index-headers.html Edgar Link pending
0001493152-24-014860-index.html Edgar Link pending
0001493152-24-014860.txt Edgar Link pending
0001493152-24-014860-xbrl.zip Edgar Link pending
bsgm-20231231.xsd Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-01.htm Edgar Link pending
ex32-01.htm Edgar Link pending
ex4-1.htm Edgar Link pending
ex97.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
bsgm-20231231_def.xml Edgar Link unprocessable
bsgm-20231231_lab.xml Edgar Link unprocessable
bsgm-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bsgm-20231231_cal.xml Edgar Link unprocessable